In this study, we evaluated the role of fiber size scale in the adhesion and spreading potential of human mesenchymal stem cells (hMSCs) on electrospun poly(caprolactone) (PCL) nanofibrous and microfibrous scaffolds. The effect of in vivo regulators in inducing osteogenic differentiation of hMSCs on PCL nanofibrous scaffolds was investigated using osteogenic differentiation marker gene expression and matrix mineralization. Here, we report for the first time the influence of in vivo regulators in an in vitro setting with hMSCs for bone tissue engineering on PCL nanofibrous matrices. Our results indicated that hMSCs attached and spread rapidly on nanofibrous scaffolds in comparison to microfibrous PCL. Further, hMSCs proliferated well on the nanofibrous scaffolds. The cells on the nanofibrous PCL were found to differentiate into the osteoblast lineage and subsequently mineralize upon addition of in vivo osteogenic regulators. The attachment and spreading of hMSCs were more effective on the nanofibers compared with the microfibers despite the lower protein surface coverage (total adsorbed protein per unit fiber surface area) on nanofibers.
Introduction

B
one tissue engineering is a field of significant research interest owing to the continued difficulty in growing natural implantable bone tissue in sufficient quantity. Attempts to generate functional bone tissue have shown increased promise after the emergence of new nanomaterialbased scaffolds. Many studies have found to favor cellmaterial interactions on nanostructured surfaces, which can help cells to adhere, spread, and proliferate on such surfaces. [1] [2] [3] Natural extracellular matrix (ECM) consists of protein-based nanofibers and nanostructured mineralized deposits that influence the adhesion, proliferation, and differentiation of the cells. [4] [5] [6] Hence, efforts to simulate the ECM through nanostructuring have received widespread attention as a means to engineer tissues in the presence of cells.
7
Electrospinning has emerged as a very viable processing option for nanostructured scaffolds consisting of nanofibrous polymeric materials. [8] [9] [10] The process has the capacity to produce three-dimensional scaffolds as well as more complex hierarchical scaffolds consisting of nano-and microstructured features.
11 Electrospun scaffolds have been investigated for bone tissue engineering by several investigators, using a variety of polymers. 12, 13 In this study our focus was to utilize this versatile method to structure both a nanofiber and a microfiber-based scaffold of poly(caprolactone) (PCL) to better understand the role of size scale of the fibers in human mesenchymal stem cell (hMSC) attachment and spreading. As pointed out in the review by Ballard et al., 14 the influence of substrate structure is directly related to the type and concentration of specific proteins adsorbed on the structures, because it is the proteins that mediate the interaction of the cells with the underlying structure. We have accordingly attempted to understand the differences in specific protein adsorption on nanofibrous versus microfibrous scaffolds to investigate possible links between the adsorption of specific proteins and the observed cell material interactions.
In our previous study, 15 we found a substantial effect of nanofibrous PCL scaffolds on the morphology and attachment of osteosarcoma cell line (MG-63). Morphologically, fibrous structures appeared to have a much stronger effect than other nanostructured surfaces on cell behavior. 16 Hence, in this study, we investigated in detail the behavior of nanofiber versus microfiber substrates in hMSC attachment and spreading. A second factor important for tissue engineering is the understanding of how in vivo factors play a 1 Amrita Centre for Nanosciences, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham University, Kochi, India. 
Introduction
Tissue engineering scaffolds made up of electrospun fibers in the nanoscale range are useful in replicating the physical dimensions and morphology of the native extracellular collagen matrix (ECM) [1] [2] [3] [4] . There have been many attempts to combine synthetic and natural polymers and/or ceramics in order to simulate the mineralized collagenous bone matrix 3 Authors to whom any correspondence should be addressed.
for tissue engineering purposes [5] [6] [7] [8] . Synthetic polymers have the advantage that their mechanical properties and degradation kinetics are more tunable when compared to natural polymers [9, 10] , which makes them attractive for tissue engineering applications. Poly( -caprolactone) (PCL) is a biocompatible, bioresorbable, Food and Drug Administration (FDA) approved low-cost synthetic and relatively strong polymer which has been successfully electrospun [11] . However, PCL is very slow to degrade (can take more than two years depending on the molecular weight) and lacks cell recognition sites on the
